Table 2 Frequency of primary and... | American Society of Hematology

Table 2

Frequency of primary and secondary outcomes per group

Outcome	Non-LR (N = 56)	LR_neonates (N = 95)	LR_non-neonates (N = 188)	P
PTS, % (n)
No	37.5% (21)	60.0% (57)	53.7% (101)	.04*
Mild	57.1% (32)	39.0% (37)	44.7% (84)
Moderate	5.4% (3)	1.0% (1)	1.6% (3)
Resolution,‡% (n)
Complete resolution	19.6% (11)	30.9% (29)	30.0% (56)	.41†
Partial resolution	55.4% (31)	40.4% (38)	43.8% (82)
No resolution or extension	25.0% (14)	28.7% (27)	26.2% (49)
Recurrence, % (n)	10.7% (6)	0	2.1% (4)	.001*
PE, % (n)	19.6% (11)	0	3.2% (6)	<.001*

Outcome	Non-LR (N = 56)	LR_neonates (N = 95)	LR_non-neonates (N = 188)	P
PTS, % (n)
No	37.5% (21)	60.0% (57)	53.7% (101)	.04*
Mild	57.1% (32)	39.0% (37)	44.7% (84)
Moderate	5.4% (3)	1.0% (1)	1.6% (3)
Resolution,‡% (n)
Complete resolution	19.6% (11)	30.9% (29)	30.0% (56)	.41†
Partial resolution	55.4% (31)	40.4% (38)	43.8% (82)
No resolution or extension	25.0% (14)	28.7% (27)	26.2% (49)
Recurrence, % (n)	10.7% (6)	0	2.1% (4)	.001*
PE, % (n)	19.6% (11)	0	3.2% (6)	<.001*

Fisher’s exact test.

χ² test.

One patient in the LR_neonate and 1 in the LR_non-neonate group did not have follow-up imaging (n = 94 and n = 187, respectively).